Matthew Goff Investment Advisor’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-6,227
Closed -$210K 79
2022
Q2
$210K Sell
6,227
-23
-0.4% -$806 0.06% 76
2022
Q1
$218K Buy
+6,250
New +$214K 0.05% 76
2021
Q4
Sell
-6,559
Closed -$215K 88
2021
Q3
$215K Sell
6,559
-78
-1% -$2.5K 0.05% 88
2021
Q2
$201K Buy
+6,637
New +$218K 0.05% 90

Other funds holding OGN

Matthew Goff Investment Advisor's OGN Position: Q3 2022 in Review

Matthew Goff Investment Advisor sold out of Organon & Co (OGN) in Q3 2022, closing a stake of 6,227 shares — an estimated $210K sold.

Matthew Goff Investment Advisor first reported a position in OGN in Q2 2021 and held it in 4 quarters. The position peaked at $218K in Q1 2022. 791 funds tracked by Wall St. Rank hold OGN as of Q3 2022.

  • Matthew Goff Investment Advisor reported no remaining Organon & Co position as of Q3 2022 after selling out during the quarter.
  • Matthew Goff Investment Advisor sold 6,227 Organon & Co shares in Q3 2022, an estimated $210K.
  • Matthew Goff Investment Advisor first reported a position in Organon & Co in Q2 2021 and held it in 4 quarters.
  • Matthew Goff Investment Advisor's Organon & Co position peaked at $218K in Q1 2022.
  • 791 funds tracked by Wall St. Rank held Organon & Co as of Q3 2022.

Based on Matthew Goff Investment Advisor's 13F filing for Q3 2022, filed 13 Oct 2022.